Recent Advances in Immune Checkpoint Inhibitors for Triple-Negative Breast Cancer
Chiara Corti,1– 4 Beyza Koca,1,2 Tasnim Rahman,1,2 Elizabeth A Mittendorf,1,2,5 Sara M Tolaney1,2,6 1Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA; 2Harvard Medical School, Boston, MA, USA; 3Division of New Drugs and Early Drug Development for Innovative Therapies, Euro...
Saved in:
| Main Authors: | Corti C, Koca B, Rahman T, Mittendorf EA, Tolaney SM |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2025-04-01
|
| Series: | ImmunoTargets and Therapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/recent-advances-in-immune-checkpoint-inhibitors-for-triple-negative-br-peer-reviewed-fulltext-article-ITT |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Current Status of Immune Checkpoint Inhibitors and Treatment Responsive Biomarkers for Triple‐Negative Breast Cancer
by: Xinran Wang, et al.
Published: (2025-05-01) -
Progress of PD-1/PD-L1 immune checkpoint inhibitors in the treatment of triple-negative breast cancer
by: Hongshu Li, et al.
Published: (2025-04-01) -
Predictive Factors of Response to Neoadjuvant Chemotherapy (NACT) and Immune Checkpoint Inhibitors in Early-Stage Triple-Negative Breast Cancer Patients (TNBC)
by: Khashayar Yazdanpanah Ardakani, et al.
Published: (2025-07-01) -
High-precision immune-related plasma proteomics profiling predicts response to immunotherapy in patients with triple-negative breast cancer
by: Yuling Xiao, et al.
Published: (2025-07-01) -
Combinational therapeutic strategies to overcome resistance to immune checkpoint inhibitors
by: Besan H. Alsaafeen, et al.
Published: (2025-04-01)